Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 7/20 | 0.48 |
| ▸ | MAOB | P27338 | 7/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.43 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17828390 | 1.00 | MAOA (0.48) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL17828395 | 1.00 | MAOA (0.48) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL29951428 | 0.82 | ALDH1A3 (0.60) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL599867 | 0.82 | ALDH1A3 (0.60) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL10591781 | 0.82 | MAOA (0.47) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL25518732 | 0.82 | MAOA (0.47) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL11665507 | 0.82 | GPBAR1 (0.55) | GPBAR1CYSLTR1ALDH1A1GAAHSD17B10 | |
| SCHEMBL10990952 | 0.81 | NPC1 (0.50) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL2551753 | 0.80 | MAOA (0.46) | MAOAMAOBNPC1RAB9ATDP1 | |
| SCHEMBL11682496 | 0.80 | SRC (0.44) | MAOAMAOBNPC1RAB9ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2017-12-07 | — | — | US | claimed |
| CN-105461585-A | 3-aminobenzamide derivative as beta-lactam auxiliary antibiotic, preparation method and application | UNIV HONG KONG POLYTECHNIC | 2016-04-06 | — | — | CN | claimed |
| US-12018228-B2 | Alkoxybenzaldehyde derivatives and precursors thereof | GIVAUDAN SA (CH) | 2024-06-25 | — | — | US | disclosed |
| US-20220002634-A1 | ALKOXYBENZALDEHYDE DERIVATIVES AND PRECURSORS THEREOF | GIVAUDAN SA (CH) | 2022-01-06 | — | — | US | disclosed |
| EP-3873880-A1 | ALKOXYBENZALDEHYDE DERIVATIVES AND PRECURSORS THEREOF | Givaudan SA (CH) | 2021-09-08 | — | — | EP | disclosed |
| CN-112930335-A | Alkoxybenzaldehyde derivative and precursor thereof | 奇华顿股份有限公司 | 2021-06-08 | — | — | CN | disclosed |
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2017-12-07 | — | — | US | disclosed |
| US-9676796-B2 | Tricyclic benzoxaborole compound, preparation method and use thereof | DONG-A ST CO., LTD. (KR) | 2017-06-13 | — | — | US | disclosed |
| US-20160168167-A1 | Tricyclic Benzoxaborole Compound, Preparation Method and Use Thereof | DONG-A ST CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| CN-105461585-A | 3-aminobenzamide derivative as beta-lactam auxiliary antibiotic, preparation method and application | UNIV HONG KONG POLYTECHNIC | 2016-04-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | BCAT2, SBDS, BCAT1 | MAOA 528/4885MAOB 110/4885NPC1 3316/4885 |
| US-20160168167-A1 | Tricyclic Benzoxaborole Compound, Preparation Method and Use Thereof | CYP2C19, CYP2C9, TBCB | MAOA 136/4885MAOB 9/4885NPC1 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.